NASDAQ · Medical - Healthcare Information Services
CERT (CERT) Stock
$8.18
+0.99%
NASDAQ: CERT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
GlobeNewswire · Jul 15, 2026
CERT: Lowering target price to $5.00
Argus Research · Jul 15, 2026
Bank of America Securities Reiterates Buy Rating on Nvidia (NVDA)
Insider Monkey · Jul 10, 2026
NVIDIA (NVDA): The Best NASDAQ 100 Stock to Buy Other Than SpaceX
Insider Monkey · Jul 9, 2026
AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development
Simply Wall St. · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held2.57%
Institutions Held109.96%
Institutions Float Held112.86%
Peer Comparison
About CERT
CERT is led by CEO Jon Resnick, employs 1,487 people, headquartered in US, publicly traded since 2020.
CERT stock trades at $8.18 with a market capitalization of $1.27B. The stock is valued at a price-to-earnings (P/E) ratio of -467.00, price-to-book of 0.68, price-to-sales of 1.94. Over the past 52 weeks the stock has ranged between $4.45 and $13.88, and currently trades 41.1% below its 52-week high.
On profitability, CERT generates a return on equity (ROE) of -0.19%, return on capital employed of 1.98%, an operating margin of 5.01%, a net profit margin of -3.60%.